HomeBUSINESS
BUSINESS

Nipro Aims at 100 Billion Yen Sales for Pharma Biz by FY2020, Seeking No. 1 Spot among Research-Oriented Makers in Generic Field
(Oct.5.2017)

Nipro Managing Director Kiyotaka Yoshioka
Nipro aims to grow its pharmaceutical segment into a 100 billion-yen business by FY2020. With the completion of the transfer of generics and long-listed products (LLPs) from Mitsubishi Tanabe Pharma, the firm has bolstered its product lineup. In the generics business field, the company aims to generate the largest sales among research-oriented companies in its earnings results ending March 2018 ...
(LOG IN FOR FULL STORY)

News Calendar